These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Recombination between feline leukemia virus subgroup B or C and endogenous env elements alters the in vitro biological activities of the viruses. Pandey R; Ghosh AK; Kumar DV; Bachman BA; Shibata D; Roy-Burman P J Virol; 1991 Dec; 65(12):6495-508. PubMed ID: 1658356 [TBL] [Abstract][Full Text] [Related]
3. Genetic diversity in the feline leukemia virus gag gene. Kawamura M; Watanabe S; Odahara Y; Nakagawa S; Endo Y; Tsujimoto H; Nishigaki K Virus Res; 2015 Jun; 204():74-81. PubMed ID: 25892717 [TBL] [Abstract][Full Text] [Related]
4. Feline leukemia virus envelope protein expression encoded by a recombinant vaccinia virus: apparent lack of immunogenicity in vaccinated animals. Gilbert JH; Pedersen NC; Nunberg JH Virus Res; 1987 Feb; 7(1):49-67. PubMed ID: 3031895 [TBL] [Abstract][Full Text] [Related]
5. Characterization and significance of delayed processing of the feline leukemia virus FeLV-FAIDS envelope glycoprotein. Poss ML; Quackenbush SL; Mullins JI; Hoover EA J Virol; 1990 Sep; 64(9):4338-45. PubMed ID: 2166820 [TBL] [Abstract][Full Text] [Related]
6. Production and Immunogenicity of FeLV Gag-Based VLPs Exposing a Stabilized FeLV Envelope Glycoprotein. Ortiz R; Barajas A; Pons-Grífols A; Trinité B; Tarrés-Freixas F; Rovirosa C; Urrea V; Barreiro A; Gonzalez-Tendero A; Rovira-Rigau M; Cardona M; Ferrer L; Clotet B; Carrillo J; Aguilar-Gurrieri C; Blanco J Viruses; 2024 Jun; 16(6):. PubMed ID: 38932278 [TBL] [Abstract][Full Text] [Related]
7. Posttranslational modifications distinguish the envelope glycoprotein of the immunodeficiency disease-inducing feline leukemia virus retrovirus. Poss ML; Mullins JI; Hoover EA J Virol; 1989 Jan; 63(1):189-95. PubMed ID: 2535725 [TBL] [Abstract][Full Text] [Related]
8. Abnormal processing of a recombinant feline leukemia virus envelope polyprotein and its interference with subgroup C virus infection. Bechtel MK; Stallcup MR; Bedgood RM; Corey JL; Pandey R; Roy-Burman P Virology; 1994 Jul; 202(1):329-38. PubMed ID: 8009844 [TBL] [Abstract][Full Text] [Related]
9. Expression of feline leukaemia virus gp85 and gag proteins and assembly into virus-like particles using the baculovirus expression vector system. Thomsen DR; Meyer AL; Post LE J Gen Virol; 1992 Jul; 73 ( Pt 7)():1819-24. PubMed ID: 1321215 [TBL] [Abstract][Full Text] [Related]
10. Replication and expression of a swinepox virus vector delivering feline leukemia virus Gag and Env to cell lines of swine and feline origin. Winslow BJ; Cochran MD; Holzenburg A; Sun J; Junker DE; Collisson EW Virus Res; 2003 Dec; 98(1):1-15. PubMed ID: 14609625 [TBL] [Abstract][Full Text] [Related]
11. Distinct superinfection interference properties yet similar receptor utilization by cytopathic and noncytopathic feline leukemia viruses. Reinhart TA; Ghosh AK; Hoover EA; Mullins JI J Virol; 1993 Sep; 67(9):5153-62. PubMed ID: 8394443 [TBL] [Abstract][Full Text] [Related]
12. Defective endogenous proviruses are expressed in feline lymphoid cells: evidence for a role in natural resistance to subgroup B feline leukemia viruses. McDougall AS; Terry A; Tzavaras T; Cheney C; Rojko J; Neil JC J Virol; 1994 Apr; 68(4):2151-60. PubMed ID: 8138999 [TBL] [Abstract][Full Text] [Related]
13. Molecular analysis and pathogenesis of the feline aplastic anemia retrovirus, feline leukemia virus C-Sarma. Riedel N; Hoover EA; Gasper PW; Nicolson MO; Mullins JI J Virol; 1986 Oct; 60(1):242-50. PubMed ID: 3018287 [TBL] [Abstract][Full Text] [Related]
14. Further development of a recombinant feline herpesvirus type 1 expressing the Gag protein of feline immunodeficiency virus. Sato E; Miyazawa T; Nishimura Y; Ikeda Y; Kawakami K; Mochizuki M; Yokoyama N; Maeda K; Fujita K; Kohmoto M; Takahashi E; Mikami T Arch Virol; 2001; 146(2):379-87. PubMed ID: 11315645 [TBL] [Abstract][Full Text] [Related]
15. Feline Leukemia Virus-B Envelope Together With its GlycoGag and Human Immunodeficiency Virus-1 Nef Mediate Resistance to Feline SERINC5. Cano-Ortiz L; Gu Q; de Sousa-Pereira P; Zhang Z; Chiapella C; Twizerimana AP; Lin C; Franco AC; VandeWoude S; Luedde T; Baldauf HM; Münk C J Mol Biol; 2022 Mar; 434(6):167421. PubMed ID: 34954236 [TBL] [Abstract][Full Text] [Related]
16. Vaccination against feline leukaemia using a new feline herpesvirus type 1 vector. Willemse MJ; van Schooneveld SH; Chalmers WS; Sondermeijer PJ Vaccine; 1996 Nov; 14(16):1511-6. PubMed ID: 9014292 [TBL] [Abstract][Full Text] [Related]
17. Protection of cats against feline leukemia virus by vaccination with a canarypox virus recombinant, ALVAC-FL. Tartaglia J; Jarrett O; Neil JC; Desmettre P; Paoletti E J Virol; 1993 Apr; 67(4):2370-5. PubMed ID: 8383248 [TBL] [Abstract][Full Text] [Related]
18. Efficient expression of the envelope protein of feline immunodeficiency virus in a recombinant feline herpesvirus type 1 (FHV-1) using the gC promoter of FHV-1. Sato E; Yokoyama N; Miyazawa T; Maeda K; Ikeda Y; Nishimura Y; Fujita K; Kohmoto M; Takahashi E; Mikami T Virus Res; 2000 Sep; 70(1-2):13-23. PubMed ID: 11074121 [TBL] [Abstract][Full Text] [Related]
19. Construction of a recombinant feline herpesvirus type 1 expressing Gag precursor protein of feline immunodeficiency virus. Sato E; Yokoyama N; Maeda K; Inoshima Y; Kohmoto M; Ikeda Y; Miyazawa T; Mikami T Arch Virol; 1998; 143(3):453-66. PubMed ID: 9572547 [TBL] [Abstract][Full Text] [Related]
20. Ancestral Mutations Acquired in Refrex-1, a Restriction Factor against Feline Retroviruses, during its Cooption and Domestication. Ito J; Baba T; Kawasaki J; Nishigaki K J Virol; 2016 Feb; 90(3):1470-85. PubMed ID: 26581999 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]